Labcorp Holdings Inc (NYSE:LH)
$ 241.16 -0.99 (-0.41%) Market Cap: 20.17 Bil Enterprise Value: 26.37 Bil PE Ratio: 46.83 PB Ratio: 2.47 GF Score: 81/100

Laboratory Corporation of America Holdings at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 01:55PM GMT
Release Date Price: $148.04 (-0.26%)
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

So good morning, everybody. I'm Ricky Goldwasser. I'm Morgan Stanley's healthcare services analyst. Before we start, just a reminder that for any personal and Morgan Stanley disclosure, please go to the Morgan Stanley website or to our desk.

So I have the very great pleasure of having the entire LabCorp executive team here. So to my left, David King, President and CEO. To Dave's left, Adam Schechter, who's the incoming CEO; and Glenn Eisenberg, LabCorp's CFO.

So Dave, Adam and Glenn, thank you for coming in kind of like for the full team.

David P. King
Laboratory Corporation of America Holdings - Chairman, CEO & President

Thanks for having us.

Questions & Answers

Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

So 2019, it's certainly had to be a transformative year for LabCorp and for the industry. We have kind of like new payer agreements. You guys are doing -- did another acquisition on the CRO side.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot